FDA grants full approval to Pfizer's Paxlovid
The Meals and Drug Administration (FDA) on Thursday granted full approval to Pfizer’s COVID-19 oral antiviral capsule Paxlovid to be...
COVID-19
COVID was fourth main reason for dying in 2022
COVID-19 was the fourth main reason for dying within the U.S. throughout 2022, after being the third main reason for...
Disaster specialists: Lack of preparedness, coordination fueled unraveling of pandemic response
A coalition of specialists present in a newly revealed report that the U.S. well being care system was uniquely deprived...
Lawmakers push again on Chinese language efforts to ‘intrude’ in COVID-19 investigation
Home lawmakers investigating the origins of the COVID-19 pandemic on Monday referred to as for the Chinese language authorities to...
China blasts WHO chief over ‘offensive’ feedback on COVID-19 origin search
Chinese language well being officers have known as out the World Well being Group’s (WHO) Director-Normal Tedros Adhanom Ghebreyesus for...
Paxlovid is secure, efficient and doesn't trigger 'rebound,' FDA says
Pfizer’s antiviral COVID-19 remedy Paxlovid is secure and efficient at treating adults with delicate to average COVID-19 who're at excessive...
Nearly 2 in 3 People say menace of lethal pandemics is rising: ballot
A brand new ballot reveals practically two-thirds of People imagine the danger of lethal pandemics is rising within the aftermath...
Home unanimously sends COVID-19 origins declassification invoice to Biden’s desk
The Home unanimously permitted a invoice on Friday that will require the director of nationwide intelligence (DNI) to declassify info...
Diabetes drug proves helpful in stopping lengthy COVID in scientific trials
COVID-19 sufferers who took the diabetes drug metformin for 2 weeks after a prognosis have been Slot Gacor Gampang Menang...
Birx: US not doing sufficient to stop one other pandemic like COVID
Dr. Deborah Birx, who served as former President Trump’s coronavirus response coordinator, mentioned on Tuesday that the U.S. isn’t doing...
